Bl 20 - analogs
| Prices in pharmacies: Instructions Bl 20 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . МенКвадфи ✘ (incl) Риалтрис Моно ✘ (incl) Флоас Моно ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 35% Sp 1 neutral
- 35% Liv 13 neutral
- 34% Sp 8 neutral
- 29% Ren 12 neutral
- 27% Sp 2 neutral
- 27% Sp 4 neutral
- 27% St 37 neutral
- 26% Ren 4 neutral
- 26% Sp 6 neutral
- 26% Sp 5 neutral
- 26% Ren 13 neutral
- 26% St 41 neutral
- 25% Gb 34 neutral
- 24% Kid 10 neutral
- 24% Bl 17 neutral
- 24% Ren 14 neutral
- 23% Lu 11 neutral
- 23% Ren 3 neutral
- 23% St 44 neutral
- 23% P 5 neutral
- 22% Kid 3 neutral
- 21% Sp 9 neutral
- 21% St 40 neutral
- 21% Bl 18 neutral
- 21% Ren 5 neutral
- 20% Kid 6 neutral
- 20% L.i. 3 neutral
- 20% Kid 7 neutral
- 20% Sp 3 neutral
- 19% St 36 neutral
- 18% P 6 neutral
- 18% Liv 14 neutral
- 18% St 45 neutral
- 18% Ren 11 neutral
- 18% L.i. 10 neutral
- 17% P 8 neutral
- 17% Ren 6 neutral
- 17% Liv 4 neutral
- 17% St 25 neutral
- 17% Bl 13 neutral
- 17% St 42 neutral
- 16% Gb 39 neutral
- 16% Lu 10 neutral
- 16% Sp 10 neutral
- 16% Bl 58 neutral
- 15% Lu 5 neutral
- 15% Ren 8 neutral
- 15% Liv 1 neutral
- 14% Gb 24 neutral
- 14% Bl 22 neutral
Learn more about the selection of analogues
- The drug has «Bl 20» no complete analogues; 51 analog by action, the most similar - Sp 1 .
- Medical online service has selected the best substitutes for Bl 20 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Bl 20 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.